InsidersTradesSigma
申报总数
公司
▲ 买入（4 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
4
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Conway Robert e, Director. Officer active across 3 companies, notably ARCA biopharma, Inc.. In total, 6 disclosures have been logged. Split: 4 buys · 1 sell. Total volume traded: €394k. Activity tracked since 5 May 2021. The latest transaction was filed on 23 September 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Conway Robert e
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
50,000 股Common StockSEC:0001626199-24-000098:0
15,000 股@ US$10.076918.9% 占其流量Common StockSEC:0001626199-21-000130:0
标准退出：2021年12月22日 (T+90)
15,000 股@ US$10.076960.6% 占其流量Common StockSEC:0001626199-21-000127:0
10,000 股@ US$9.796639.4% 占其流量Common StockSEC:0001626199-21-000120:0
标准退出：2021年12月20日 (T+90)
10,000 股@ US$3.194749.5% 占其流量Common StockSEC:0001209191-21-032381:0
标准退出：2021年8月10日 (T+90)
10,000 股@ US$3.234550.5% 占其流量Common StockSEC:0001209191-21-030629:0
标准退出：2021年8月3日 (T+90)
6 条申报中的 6 条
About Conway Robert e
Robert E. Conway is a Director of ARCA biopharma, Inc. and ALPINE IMMUNE SCIENCES, INC. He brings extensive experience in corporate governance and strategic decision-making. His role involves overseeing the company's activities and ensuring that shareholder interests are safeguarded. His contribution is essential in guiding these companies within the biopharmaceutical sector.
